Disclosure, comfort, and negative experiences with HIV care providers among transgender women living with HIV in Canada: Findings from a prospective cohort study of women living with HIV in Canada
Open Access
- 1 November 2025
- journal article
- Published by SAGE Publications in Women's Health
- Vol. 21
Abstract
Background: Transgender (trans) women living with HIV often face barriers to accessing inclusive and comprehensive primary and HIV care. Objectives: We aimed to (1) describe differences in trans women’s disclosure of their trans identity and comfort discussing trans identity and trans-specific healthcare needs, based on physician type, and (2) report on the prevalence of negative trans-specific experiences with HIV physicians and any provider-related factors associated with comfort. Design: Data of trans participants in the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS) were analyzed across three waves (2013–2018). Methods: Descriptive statistics explored disclosure of trans identity and comfort discussing trans-specific healthcare needs with family physicians versus HIV physicians. Fisher’s exact tests of association explored the relationship between provider-related factors and self-reported comfort. Prevalence of negative trans-specific experiences with HIV physicians was reported. Results: At baseline, of 54 trans women, 39 (72.2%) had a physician who supervised their HIV care in the year preceding (HIV physician). Among this subset, 94.9% had disclosed their trans identity and 82.1% reported feeling comfortable discussing trans-specific healthcare needs with this physician. Of the 27 (50.0%) who reported having a regular family physician other than their HIV care provider, 92.6% had disclosed their trans identity and 88.9% were comfortable discussing trans-specific healthcare needs. The most prevalent negative trans-specific experience with HIV physicians reported cumulatively was being told by the physician that they did not know enough about trans-related care to provide care (16.7%). Conclusion: Our findings demonstrate a high prevalence of disclosure of trans identity to physicians among our trans participants. Our findings suggest trans women have similar comfort discussing trans-specific healthcare needs with their family and HIV physicians; however, negative experiences with HIV providers indicate the need for gender-affirming, trans-specific provider training.Keywords
Funding Information
- Canada Research Chairs
- Academic Health Science Centres
- Santé
- Canadian HIV Trials Network, Canadian Institutes of Health Research (CTN 262)
- Ontario HIV Treatment Network
- Canadian Institutes of Health Research
This publication has 38 references indexed in Scilit:
- Factors Impacting Transgender Patients’ Discomfort with Their Family Physicians: A Respondent-Driven Sampling SurveyPLOS ONE, 2015
- Factors associated with healthcare avoidance among transgender women in ArgentinaInternational Journal for Equity in Health, 2014
- Evidence of the Negative Effect of Sexual Minority Stigma on HIV Testing Among MSM and Transgender Women in San Salvador, El SalvadorAIDS and Behavior, 2014
- HIV epidemics among transgender womenCurrent Opinion in HIV and AIDS, 2014
- Barriers and Facilitators to Engagement and Retention in Care among Transgender Women Living with Human Immunodeficiency VirusAnnals of Behavioral Medicine, 2013
- Worldwide burden of HIV in transgender women: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2013
- Syndemic Theory and HIV-Related Risk Among Young Transgender Women: The Role of Multiple, Co-Occurring Health Problems and Social MarginalizationAmerican Journal of Public Health, 2012
- Transgender identity and health care: Implications for psychosocial and physical evaluationJournal of the American Academy of Nurse Practitioners, 2011
- HIV in Transgender Communities: Syndemic Dynamics and a Need for Multicomponent InterventionsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studiesBMJ, 2007